Target intelligence / Profile preview

A9 subtype ventral midbrain dopaminergic neuron

Molecular classification
Neuron (specifically, dopaminergic neuron), Neurotransmitter-producing cell, Other (cell type)
01

Overview

The A9 subtype ventral midbrain dopaminergic neurons are specialized neurons located in the substantia nigra pars compacta of the midbrain. They are responsible for the majority of dopamine production that regulates motor control, motivation, and reward-related behaviors. Degeneration of these neurons is the primary cause of dopamine deficiency in Parkinson’s disease. Restoration of dopamine production through the differentiation and transplantation of stem-cell-derived A9 dopaminergic neurons is a promising therapeutic strategy for treating Parkinson's disease and related disorders. The success of this approach depends on accurately generating and grafting these specific neuron subtypes, as they uniquely innervate the dorsolateral striatum and are essential for effective motor recovery[1][3][4][5][6].

Other names
A9 dopamine neuronsubstantia nigra pars compacta dopaminergic neuronmidbrain dopaminergic neuron (A9 subtype)
02

Mechanism of action

Replacement of lost dopaminergic neurons to restore dopamine production; Restoration of nigrostriatal pathway function; Direct neurotransmitter supplementation (indirect, via drugs)

03

Biological functions

Dopamine synthesis and releaseMotor controlRegulation of voluntary movementReward processingMotivation regulation
04

Disease associations

Neurodegenerative disease (specifically, Parkinson’s disease)Psychiatric disorders (e.g., those involving the reward system)
05

Safety considerations

Graft-induced dyskinesiasOvergrowth or tumor formation from transplanted cellsImmune rejection of transplanted tissueIncorrect cell differentiation
06

Interacting drugs

Levodopa

3 more in the full profile.

07

Biomarkers

Tyrosine hydroxylase (TH) expressionDopamine transporter (DAT) levelsPitx3 gene expressionImaging of dopamine uptake and metabolism (e.g., PET scans)

Beyond the preview

Go deeper on A9 subtype ventral midbrain dopaminergic neuron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A9 subtype ventral midbrain dopaminergic neuron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call